What does net proceeds from cvr liability settlement mean?

This metric captures the net cash impact resulting from the settlement of Contingent Value Rights (CVR) obligations. It reflects payments made to or received from holders of rights tied to specific future performance milestones or clinical outcomes. This is a critical indicator for assessing the financial impact of legacy acquisition agreements or specific performance-based liabilities.

Gyre Therapeutics, Inc. GYRE Net Proceeds From Cvr Liability Settlement

Net Proceeds From Cvr Liability Settlement at other companies

i3 Verticals, Inc.IIIV

$55.25K-94.8%

Golub CapitalGBDC

-$10.26M-266%

Angel Studios, Inc.ANGX

$4.16M+8,758%

LendingTreeTREE

-$20K+99.9%

Williams CompaniesWMB

$156.75M—

Macy'sM

$82M—

Other financials

Income statement

See full

Revenue$22.5M+2.1%

Gross profit$21.3M+0.6%

Operating income-$9.4M-512%

Net income-$8.7M-422%

EPS (diluted)-$0.10—

Balance sheet

See full

Cash & equivalents$37.5M+149%

Total debt$823.0K-48.1%

Total equity$101.3M+48.7%

Total assets$162.0M+24.8%

Cash flow

See full

Operating cash flow$3.2M+2,565%

CapEx$178.0K+45.9%

Free cash flow$3.0M+1,296%

Valuation

See full

Market cap$694.58M-4.7%

Enterprise value$657.9M-8.0%

P/S5.9×-1.3×

Profitability

See full

Gross margin95.1%-1.1pp

Operating margin-0.1%-10.4pp

Net margin6.3%+3.3pp

FCF margin2.6%—

Returns & leverage

See full

Return on equity8.2%+4.2pp

Debt / equity0×0.0×

Current ratio4.6×+1.0×

Where this comes from

Reported directly by Gyre Therapeutics, Inc. in its filing.

Tagged under the XBRL concept gyre:NetProceedsFromCvrLiabilitySettlement.

The official record: Gyre Therapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Gyre Therapeutics, Inc.'s net proceeds from cvr liability settlement.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Gyre Therapeutics, Inc.'s net proceeds from cvr liability settlement?: Gyre Therapeutics, Inc. (GYRE) reported net proceeds from cvr liability settlement of $25K in Q1 2025.
What does net proceeds from cvr liability settlement mean?: This metric captures the net cash impact resulting from the settlement of Contingent Value Rights (CVR) obligations. It reflects payments made to or received from holders of rights tied to specific future performance milestones or clinical outcomes. This is a critical indicator for assessing the financial impact of legacy acquisition agreements or specific performance-based liabilities.